• Our People
  • Global Presence
  • Regions
    • Asia
    • Europe
    • Americas
  • Offices
    • Canada
      • Ottawa
      • Toronto
    • China
      • Beijing
      • Hong Kong
    • Luxembourg
    • Malaysia
    • Singapore
    • UK
      • Aberdeen
      • Birmingham
      • Cambridge
      • Edinburgh
      • Glasgow
      • London
      • Manchester
      • Oxford
  • Client liaison
    • Japan
    • Korea
  • Expertise
  • Services
    • Patents
    • Brands & Trade Marks
    • Designs
    • Litigation & Dispute Resolution
    • Commercial IP & Contracts
    • Due Diligence
    • Freedom to Operate
    • EPO Patent Oppositions
    • European Patent Validations
    • Anti-counterfeiting
    • Open Source & Third Party Code
  • Sectors
    • Digital Transformation
      • 3D Printing
      • Artificial Intelligence
      • Blockchain
      • Data & Connectivity
      • Extended Reality
      • Industry 4.0
    • Energy & Environment
    • Life Sciences
    • Agritech
    • Medical Technologies
    • Chemistry
    • Transport
    • Entertainment & Creative Industries
    • Food & Drink
    • Fashion & Retail
    • Universities & Research Bodies
    • Start-ups & Spin-outs
      • Creating value for start-ups
      • The IP driven start-up
    • Financial Services
  • About Us
    • Working with us
    • Awards
    • Corporate & Social Responsibility
    • Diversity & Inclusion
    • Careers
  • Insights
    • Articles
    • News
    • Events
    • Resources
    • Unified Patent Court hub
    • Beyond Brexit: European trade mark hub
    • M&C Reacts
  • Contact Us
Marks & Clerk logo
Marks & Clerk logo
Contact Us
Language
English
Our People
Global Presence
Regions
  • Asia
  • Europe
  • Americas
Offices
  • Canada
    • Ottawa
    • Toronto
  • China
    • Beijing
    • Hong Kong
  • Luxembourg
  • Malaysia
  • Singapore
  • UK
    • Aberdeen
    • Birmingham
    • Cambridge
    • Edinburgh
    • Glasgow
    • London
    • Manchester
    • Oxford
Client liaison
  • Japan
  • Korea
Expertise
Services
  • Patents
  • Brands & Trade Marks
  • Designs
  • Litigation & Dispute Resolution
  • Commercial IP & Contracts
  • Due Diligence
  • Freedom to Operate
  • EPO Patent Oppositions
  • European Patent Validations
  • Anti-counterfeiting
  • Open Source & Third Party Code
Sectors
  • Digital Transformation
    • 3D Printing
    • Artificial Intelligence
    • Blockchain
    • Data & Connectivity
    • Extended Reality
    • Industry 4.0
  • Energy & Environment
  • Life Sciences
  • Agritech
  • Medical Technologies
  • Chemistry
  • Transport
  • Entertainment & Creative Industries
  • Food & Drink
  • Fashion & Retail
  • Universities & Research Bodies
  • Start-ups & Spin-outs
    • Creating value for start-ups
    • The IP driven start-up
  • Financial Services
About Us
  • Working with us
  • Awards
  • Corporate & Social Responsibility
  • Diversity & Inclusion
  • Careers
Insights
  • Articles
  • News
  • Events
  • Resources
  • Unified Patent Court hub
  • Beyond Brexit: European trade mark hub
  • M&C Reacts

The ‘Fighting Coronavirus’ platform

02 October 2020
Liam O'Connor
Print
Share

It is often said that times of crisis facilitate and accelerate innovation. The Covid-19 pandemic has presented urgent challenges on a global scale, ranging from the preservation of economic activity, to preventing the spread of novel coronavirus SARS-CoV-2 and saving lives. Perhaps recognising this, the EPO has recently launched a platform, ‘Fighting Coronavirus’, to facilitate knowledge transfer from published patent applications to those involved in the development of technologies to counter Covid-19.

As we know, patent applications often provide a wealth of information, which can guide innovators in solving problems and devising new inventions. However, it can be difficult to navigate the sheer volume of information in the patent system. Instead, innovators might tend to favour peer-reviewed journals as their primary source of information, meaning the information published in patent applications is largely ignored and underused.

The ‘Fighting Coronavirus’ platform provides extremely useful pre-configured searches, which will direct the user to patents or patent applications describing relevant technologies. These pre-configured searches represent a quick and effective means of reviewing existing patent literature in a subject area, and avoids the need to use classification codes normally used to categorise applications. Some of the pre-configured searches include:

Vaccines and Therapeutics

  • Vaccines against coronaviruses, including viral vectors, nucleic acid-based vaccines, antigen-presenting cells, and administration of vaccines.
  • Drug candidates (small-molecules, peptides) which may be effective against Covid-19 both as antivirals, and in the relief of Covid-19 symptoms.
  • Nucleic acid based treatments and therapies targeting coronaviruses (e.g. nucleic acid inhibitors, antisense oligonucleotides, interfering RNA, aptamers)
  • Antibodies as therapies against coronavirus.

Diagnostics & Analytics

  • Methods and assays for detecting viruses in patients and the environment
  • Devices for analysing virus samples in vitro
  • Imaging of viruses and related disease states in vitro and in vivo
  • Devices for clinical diagnosis and treatment (e.g. oximeters)

Informatics

  • Analysis of data pertaining to viral properties (e.g. mutations, infection pathways).
  • Healthcare detection, management, treatment and protection from coronavirus.

The platform also provides useful data analysis and information tools. An indication of the top applicants and top inventors for coronavirus related applications in particular subject areas is provided, along with an indication of the most prolific countries for coronavirus related patent filings within Europe and worldwide. These data provide interesting insights into the intensity of the research being carried out globally.

In our view, the ‘Fighting Coronavirus’ platform is a valuable reservoir of information, that is ripe for mining by those involved in overcoming the challenges presented by Covid-19.

Next Story
  • How to accelerate your Covid-19 related UK patent application
  • In the wake of the Covid-19 lockdown, XR also goes viral
  • Patent protection in the time of Covid-19
  • Webinar: Implications of Covid-19 on the future of IP, insurance & cybersecurity
More insights

Latest Insights

Black bike seat on an orange frame
Article
- 07 February 2023

To see, or not to see?

There is an interesting question to be answered – to what extent does a design detail need to be visible in order for it to be a part of the scope of protection of a registered design for a complex product
Read more
Beakers and historical buildings interlaced on a Cambridge backdrop
Article
- 07 February 2023

Cambridge: City of Innovation - 70 Years of the Cambridge DNA Revolution

Cambridge has laid claim to many historic scientific achievements in the 800 years since the foundation of its University. Amongst them, the the elucidation of the double helix structure of DNA, which took place 70 years ago.
Read more
two festive gin bottles glowing with gold pieces floating inside, sitting alongside two out of focus festive cocktails
Article
- 03 February 2023

Marks & Spencer lights up Aldi design infringement

Marks & Spencer has successfully enforced several UK registered designs against Aldi’s copycat products in a decision that should provide welcome reassurance for designers seeking to use registered designs to protect their products.
Read more
Marks & Clerk logo (white)
  • Terms & Conditions
  • Privacy Notice
  • Cookies
  • Legal Notices
  • Lexology
  • Mondaq